Systematic review of immunosuppressant guidelines in the COVID-19 pandemic

AIMS: Individuals taking immunosuppressants are at increased susceptibility to viral infections in general. However, due to the novel nature of the COVID-19, there is a lack of evidence about the specific risks of the disease in this patient group. This systematic review aims to summarize the curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Barlow-Pay, Fenella, Htut, Thura Win, Khezrian, Mina, Myint, Phyo Kyaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882764/
https://www.ncbi.nlm.nih.gov/pubmed/33628418
http://dx.doi.org/10.1177/2042098620985687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882764/
https://www.ncbi.nlm.nih.gov/pubmed/33628418
http://dx.doi.org/10.1177/2042098620985687

Ejemplares similares